These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B]. VENTURA S, COLI L. Haematologica; 1964; 49():252-73. PubMed ID: 14217827 [No Abstract] [Full Text] [Related]
27. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE. WOEHLER F. Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792 [No Abstract] [Full Text] [Related]
28. Studies of iron kinetics using a linear scanner. I. Distribution of sites of uptake of plasma iron in hematological disorders. Alfrey CP, Lynch EC, Hettig RA. J Lab Clin Med; 1969 Mar; 73(3):405-17. PubMed ID: 5766186 [No Abstract] [Full Text] [Related]
30. [Autoimmune hemolytic anemia as a symptom of systemic reticuloendotheliosis in the senile age]. BELLETTINI W. G Gerontol; 1962 Aug; 10():857-64. PubMed ID: 13970487 [No Abstract] [Full Text] [Related]
32. [THE SIGNIFICANCE OF SERUM IRON CONTENT AND IRON-BINDING PROTEIN IN THE DIFFERENTIAL DIAGNOSIS OF VARIOUS DISEASES]. BRUESCHKE G, HERRMANN H, ISRAEL S. Z Arztl Fortbild (Jena); 1964 Feb 01; 58():142-6. PubMed ID: 14151714 [No Abstract] [Full Text] [Related]
35. [Secondary hemochromatosis of hematologic origin]. Dresch C, Najean Y, Bernard J. Ann Med Interne (Paris); 1971 Dec 01; 122(12):1213-6. PubMed ID: 5151625 [No Abstract] [Full Text] [Related]
36. [THERAPEUTIC AGENTS IN HEMOBLASTOSIS]. KLENER P. Lek Veda Zahr; 1964 May 15; 5():81-5. PubMed ID: 14159079 [No Abstract] [Full Text] [Related]